what happens when you stop taking glp-1 medication weight-loss drugs? Half of GLP-1 users ditch

More than half of subjects in a clinical trial for Semaglutide lost at least 10 percent of their body weight

Venus Legacy uses multipolar radiofrequency combined with pulsed electromagnetic fields to heat the tissue and stimulate fibroblast activity

This timing helps the active ingredients work well with food intake, maximizing their effect on blood glucose levels after eating

Moreover, they are associated with a very low risk of hypoglycemia, owing to their glucose-dependent mechanism of action mediated by GLP-1 [49]

However, our exclusion of patients with pre-existing vestibular diagnoses mitigates this concern

Some patients may have received a prescription but ultimately were unable to fill it due to insurance coverage, cost-sharing requirements, or pharmacy-level barriers